US News Bulletin report

Medicare for All’s $47 Trillion Question Is Really About Access


A $47 trillion estimate is the kind of number that makes people stop reading. It is too large to picture, too abstract to feel, and easy to turn into a political weapon. But behind Dr. Mehmet Oz’s warning about Medicare for All is a question that matters to anyone who has waited for an appointment, skipped a prescription, or feared a hospital bill: what would a national health plan actually cost, and who would be able to get care?

Oz, the administrator of the Centers for Medicare & Medicaid Services, warned that Medicare for All could cost $47 trillion over the next decade. He argued that the proposal could create a two-tier healthcare system and restrict access to doctors and lifesaving treatments. He also said the plan would be “not Medicare for all, it’s Medicaid for all,” claiming that wealthier people would buy the care they want while everyone else would be left with what remains.

That is a serious claim. It is also a prediction, not a settled fact.

What the number means

Oz cited an estimate from the Council of Economic Advisers. The $47 trillion figure refers to the potential cost of a Medicare for All program over ten years. He said that even the most aggressive Democratic tax proposals could raise only about half of that amount, leaving a roughly $25 trillion gap.

The number deserves attention. But it should not be treated as a final verdict on the idea.

Cost estimates for Medicare for All vary widely because the details matter. A plan’s scope, provider payment rates, drug pricing rules, administrative savings, and financing choices can change the total substantially. Marc Goldwein of the Committee for a Responsible Federal Budget has estimated that a Medicare for All program could cost the government $20 trillion to $40 trillion over a decade, depending on its design.

So the honest answer is not that the plan would certainly cost $47 trillion. The honest answer is that a broad single-payer program would cost an enormous amount, and its backers would need to explain exactly how they would pay for it without shifting costs onto people who cannot afford them.

The problem already exists

It would be a mistake to pretend the current system is affordable simply because a proposed alternative is expensive.

National health spending totaled $5.3 trillion in 2024, or $15,474 per person, according to the Centers for Medicare & Medicaid Services. The agency projects spending will reach nearly $9.0 trillion by 2034, when it would account for 20.6 percent of the economy.

That means the country is already paying a very large amount for healthcare. The question is not whether Americans will spend trillions. They already do. The question is whether the money is spent efficiently, whether coverage is dependable, and whether patients can reach care when they need it.

CMS projects that health spending will reach $6.0 trillion in 2026. Hospitals account for the largest share of that spending, at $1.9 trillion.

Those figures do not settle the Medicare for All debate. They do make the debate harder to dismiss.

Access is the real test

Oz’s warning about a two-tier system is worth taking seriously, even if the outcome is not guaranteed. Any health system has limits: doctors, hospital beds, specialists, medicines, and staff are finite. The issue is how those limits are managed, and who bears the consequences when they are not.

A public insurance program can promise broad coverage on paper. It cannot automatically create more primary-care doctors, more oncologists, more nurses, or more affordable housing near a hospital. If reimbursement rates are too low, some providers may limit participation. If demand rises while capacity stays the same, waits can grow. Those are practical problems, not slogans.

But the present system has its own access problem. Insurance can be costly, narrow, confusing, or tied to a job. A person can have coverage and still face deductibles, copays, out-of-network bills, and prescription costs that make treatment difficult to sustain. The insured share of the population is projected to fall from 91.8 percent in 2024 to 90.5 percent in 2034, according to CMS projections.

That is why the argument cannot be reduced to “government plan versus private insurance.” Both systems can fail people. The difference is in how they fail, who pays, and whether patients have a real choice when care is needed.

What remains unknown

The documented fact is that Oz made the $47 trillion claim and warned about access and a two-tier system. The disputed part is whether that estimate accurately describes a particular Medicare for All proposal, and whether the predicted access problems would occur.

There is no single Medicare for All bill with one fixed price tag that everyone agrees on. Different proposals cover different benefits, pay providers differently, and raise money differently. Until those choices are specified, a ten-year cost estimate is more like a warning label than a final invoice.

I understand why the $47 trillion figure alarms people. It should. A number that large means the financing plan cannot be vague. It means lawmakers would have to say whose taxes would rise, which benefits would change, and what would happen to employers, hospitals, drugmakers, and state budgets.

But concern about cost should not become an excuse to ignore the costs people already carry. A family does not experience healthcare as a trillion-dollar projection. It experiences it as a bill, a denied claim, a delayed appointment, or a prescription that has to wait until payday.

What a serious debate needs

The useful question is not whether Medicare for All sounds generous or frightening. It is whether a specific plan would make care more available, more affordable, and more reliable than the system people use now.

That requires answers to basic questions. How would the program be financed? What would doctors and hospitals be paid? Would prescription drug prices be negotiated? Would dental, vision, hearing, mental health, and long-term care be included? What happens to private insurance? And what would prevent a coverage guarantee from becoming a promise without enough clinicians to meet it?

Those are not small details. They are the difference between a plan that expands access and one that merely changes who sends the bill.

The $47 trillion estimate should be examined, challenged, and compared with other estimates. It should not be accepted as proof that reform is impossible. Nor should it be waved away because the current system is already expensive.

People need healthcare that works when they are sick. They need to know what care will cost before they receive it. They need doctors who are available and medicines they can afford. Any proposal, public or private, should be judged by whether it moves the country closer to that standard.

Explore: Politics